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Dear Editor,
We highly appreciate the comments by Drs. Wang, Horng and
Lee regarding our feasibility study on prevention of radiation
cystitis by intravesical instillations with chondroitin sulphate
[1]. We fully agree that more pre-clinical studies may help to
elucidate the mechanisms and treatment of radiation cystitis,
and that several clinical studies are needed to assess the efficacy
ofintravesical instillationswithchondroitin sulphate. Infact,we
hope soon to start a double-blind study in patients undergoing
primary or adjuvant radiotherapy for gynaecological malignan-
cies. In that trial, a wider range of early and late clinical
symptoms will be evaluated, as also suggested by Wang et al.
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